In addition, and similar to our findings in murine models, blocking RAC1 in Krasmut cells, but not Nrasmut cells, from CMML patients caused a reduction of IL-1β expression and ROS production (Fig. 9k, l, Supplementary Fig. S5H, I). Here, IL1B is linked to chronic myelomonocytic leukemia.